| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |